S P E C I A L A D V E R T I S I N G S E C T I O N

OSN New York 2014 Product Showcase

Abbott Medical Optics is focused on delivering life-improving vision tech-nologies to people of all ages. The company offers a comprehensive port-

folio of cataract, refractive and eye care products. Products in the cataract line include laser cataract technology, monofocal and multifocal intraocular lens-es, phacoemulsification systems and viscoelastics. Products in the refractive line include wavefront diagnostic devices, femtosecond lasers and associated patient interface devices; excimer laser vision correction systems and treat-ment cards. Eye care products include disinfecting solutions, enzymatic clean-ers, lens rewetting drops and artificial tears. AMO is headquartered in Santa Ana, Calif., employing approximately 4,000 worldwide. For more information, visit www.abbottmedicaloptics.com.

Abbott Medical Optics1700 East St. Andrew PlaceSanta Ana, CA 92705www.abbottmedicaloptics.comBooth # 7

The Cataract Refractive Suite by Alcon consists of best-in-class technolo-gies for every phase of the procedure, redefining the way cataract sur-

gery is performed from start to finish. More than just the sum of its parts, this industry-leading suite is designed to deliver powerful performance for you, your clinic and your patients. By continuously optimizing your perfor-mance, it allows you to maximize your skill and outcomes. Experience the benefits of increased surgical efficiencies, greater confidence to recommend multifocal and toric IOLs and optimized outcomes based on your patients’ unique needs.

Alcon Laboratories6201 South FreewayFort Worth, TX 76134www.alcon.comBooth # 21, 22

E xhibitors at the Ocular Surgery NewS New York 2014 Symposium were invited to send a description of prod-

ucts that will be displayed at this year’s meeting, to be held in New York City on November 14-16. All claims made in the descriptions are those of the manufacturer. Appearance of a product does not constitute an endorsement by Ocular Surgery NewS, the publisher or the Editorial Board.

Product Showcase

Exhibit Hall ListingsAbbott Medical Optics ...................................... 7

Alcon .........................................................21, 22

Bausch + Lomb .............................................1, 2

Carl Zeiss Meditec ........................................... 15

Diopsys Inc. ................................................... 29

Doctors Allergy Formula ................................. 32

DoctorsInternet.com ...................................... 31

Healio.com/Ocular Surgery NewS ............24, 25

Heidelberg Engineering ................................. 26

i-Optics .......................................................... 30

Imprimis ........................................................ 10

Katena Products Inc. ........................................ 4

Ocular Therapeutix Inc. . ................................. 18

Omeros Corporation ....................................... 14

Perrigo Specialty Pharmaceuticals ................. 28

PRN Physician Recommended Nutriceuticals ... 5

Sightpath Medical .......................................... 27

SLACK Incorporated ...................................24, 25

Synergetics ..................................................... 20

TearLab Corp. ................................................... 8

26

S P E C I A L A D V E R T I S I N G S E C T I O N

OSN New York 2014 Product Showcase

Bausch + Lomb, a Valeant Pharmaceuticals International, Inc., company, is a leading global eye health organization that is solely focused on protect-

ing, enhancing, and restoring people’s eyesight. Our core businesses include ophthalmic pharmaceuticals, contact lenses and lens care products, and oph-thalmic surgical devices and instruments. We globally develop, manufacture and market one of the most comprehensive product portfolios in our indus-try, which are available in more than 100 countries.

Bausch + Lomb400 Somerset Corporate Blvd.Bridgewater, NJ 08807www.bausch.comBooth # 1, 2

Diopsys Inc. is a medical instrumenta-tion company dedicated to deliver-

ing high-quality, cost-effective preventa-tive health care solutions. We specialize in the development and marketing of patient-friendly, noninvasive vision test-ing equipment utilizing electrophysiolo-gy, including visual evoked potential and pattern electroretinography. Diopsys has developed and markets the patented Di-opsys Nova-VEP and Diopsys Nova-ERG Vision Testing Systems utilized by oph-thalmologists and optometrists to help in the detection, diagnosis and treatment of vision disorders, including glaucoma and macular degeneration.

Diopsys Inc.16 Chapin Road, Suite 912Pine Brook, NJ 07058www.diopsys.comBooth # 29

C arl Zeiss is one of the world’s leading medical technology companies. The company supplies innovative technologies and application-oriented

solutions designed to help doctors improve the quality of life of their patients. It provides complete packages of solutions for the diagnosis and treatment of eye diseases, including implants and consumables. The company creates innovative visualization solutions in the field of microsurgery. The medical technology portfolio of Carl Zeiss Meditec is rounded off by promising fu-ture-oriented technologies such as intraoperative radiotherapy.

Carl Zeiss Meditec5160 Hacienda Dr.Dublin, CA 94568www.meditec.zeiss.comBooth # 15

Doctors Allergy Formula (DAF) is proud to be the company to bring in-office ocular allergy diagnostic testing to ophthalmology. Our FDA-

approved turn-key system provides ophthalmologists with the tools to objec-tively diagnose and get to the root cause of ocular allergies to then prescribe a customized treatment protocol. DAF is noninvasive (no needles) and tests for 60 ocular-specific, regionalized allergens. The test is covered by all major medical insurance with a $420 average Medicare allowable and is tech-driven taking 2 minutes to perform. With more than 1,000 leading ophthalmologists as DAF providers, DAF is quickly becoming standard-of-care for OSD and associated ocular allergies.

Doctors Allergy Formula2375 St. John’s Bluff Road South, Unit 310Jacksonville, FL 32246www.drsallergy.comBooth # 32

27

S P E C I A L A D V E R T I S I N G S E C T I O N

OSN New York 2014 Product Showcase

Cassini: True corneal shape analysis, essential for premium IOL plan-ning. Cassini is a corneal shape analyzer based on patented color LED

technology. It offers true measurement of corneal astigmatism for premium surgical planning. The true axis and magnitude of astigmatism plays a vital part in the correct selection and positioning of premium IOLs. Cassini’s patented technology offers the accuracy and precision essential for pre-mium IOL planning and is the critical addition to the cataract-refractive platform. See things different.

i-Optics110 Turnpike Road, Suite 108Westboro, MA 01580www.i-optics.comBooth # 30

DoctorsInternet.com is a company that markets our doctors’ websites on-line in an effort to place well in Google, Bing and other search engines’

search results for the keywords and phrases important to ophthalmology. We also manage a doctor’s online persona by making it simple to generate positive reviews from a doctor’s best patients and we monitor our doctor’s online repu-tation as well. We can work with a doctor’s existing website or we will design a new website for free. DoctorsInternet.com will get a doctor to place on page one of Google searches in their town or neighborhood.

DoctorsInternet.com15 Ward DriveNew Rochelle, NY 10804www.doctorsinternet.comBooth # 31

Healio.com, the online home of Ocular Surgery News, offers daily news updates, online only content, extensive CME and specialized

email news wires. Download the new Healio.com/Ocular Surgery News App on iTunes – Search “Ocular Surgery News.” As the best-read newspaper for ophthalmologists, Ocular Surgery News holds a unique place among eye care publications. With the largest dedicated staff focused solely on ophthalmology, OSN strives to bring our readers a deeper un-derstanding of the news and events that affect their profession.

Healio.com/Ocular Surgery NewS6900 Grove RoadThorofare, NJ 08086Healio.com/OphthalmologyBooth # 24, 25

S pectralis OCT with MultiColor. MultiColor imaging is now available on all new Spectralis models, providing additional diagnostic power by high-

lighting structural detail from different depths within the retina. MultiColor imaging expands the power of Spectralis for retina, glaucoma and anterior segment applications. Features include multi-modality imaging, TruTrack ac-tive eye tracking, 1-µm reproducibility, upgradeable hardware platform, and comprehensive DICOM compatibility.

Heidelberg Engineering1808 Aston Ave., Suite 130Carlsbad, CA 92008www.HeidelbergEngineering.comBooth # 26

28

S P E C I A L A D V E R T I S I N G S E C T I O N

OSN New York 2014 Product Showcase

Omeros is a Seattle-based biopharmaceutical company committed to dis-covering, developing and commercializing small-molecule and protein

therapeutics targeting inflammation, coagulopathies and CNS disorders for large-market as well as orphan indications. Its first FDA-approved product is Omidria (phenylephrine and ketorolac injection) 1%/0.3% for use during lens replacement surgery. The company has six clinical stage programs focused on complement-related thrombotic microangiopathies; Huntington’s disease, schizophrenia, and cognitive impairment; addictive and compulsive disorders; and problems associ-ated with surgical procedures. Omeros’ pipeline also includes a diverse group of preclinical programs and two drug-development platforms: one that unlocks new GPCR drug targets and another used to generate antibodies.

Omeros Corporation201 Elliot Ave. WSeattle, WA 98119www.omeros.comBooth # 14

I mprimis Pharmaceuticals invites you to booth #10 to learn about our Go Dropless! Campaign and our proprietary ophthalmic sterile injectable

compounded formulations. Our goal is to inform ophthalmologists and to shift the treatment paradigm in the cataract surgery drug market and other markets in ophthalmology. Our patent-pending therapies were developed to alleviate surgeon concerns about patient compliance and spare patients the expense and aggravation of postoperative eye drops. To learn more, please visit www.GoDropless.com or www.imprimispharma.com.

Imprimis Pharmaceuticals Inc.12264 E. Camino Real, Suite 350San Diego, CA 92126www.imprimispharma.comBooth # 10

Katena/IOP is proud to exhibit at the 2014 OSN meeting in New York. Many new items will be displayed including new instruments for MICS,

DMEK, MGD and laser-assisted cataract surgery. All of our amniotic mem-brane allografts (AmbioDisk, Ambio2, Ambio5) will be featured as well as our full line of Tutoplast processed patch grafts (pericardium, sclera and clear cornea). Also, the Molteno3 tube shunt will be on display for use in glaucoma procedures.

Katena Products Inc.4 Stewart CourtDenville, NJ 07834www.katena.comBooth # 4

The ReSure Sealant is a novel hydrogel which is applied as a liquid and gels in situ over corneal incisions for the prevention of fluid egress fol-

lowing cataract surgery. It is the first ocular sealant approved for ophthalmic use in the United States.

Ocular Therapeutix Inc.36 Crosby Drive, Suite 101Bedford, MA 01730www.ocutx.comBooth # 18

29

S P E C I A L A D V E R T I S I N G S E C T I O N

OSN New York 2014 Product Showcase

PRN-Physician Nutriceuticals is a leading developer of specialty omega-3 products and nutritional supplements for macular health and dry eye

symptom relief. PRN’s Eye Health portfolio includes three products. Dry Eye Benefits offers natural relief for dry eye symptoms in a potent re-esterified triglyceride form of omega-3 (EPA/DHA). Eye Omega Advantage supports macular health through a re-esterified triglyceride formulation of omega-3 (EPA/DHA) and the addition of lutein and zeaxanthin. Macular Vitamin Ben-efits is an improved version of the AREDS 2 formula with lutein, zeaxanthin, zinc, a full vitamin B complex, and all natural tocopherol/tocotrienol forms of vitamin E.

PRN-Physician Recommended Nutriceuticals502 West Germantown Pike, Suite 610Plymouth Meeting, PA 19462www.prnomegahealth.comBooth # 5

Perrigo company plc is a leading global health care supplier. Perrigo develops, manufactures and distributes branded products, including

Bacitracin, over-the-counter (OTC) and generic prescription (Rx) pharma-ceuticals, nutritional products and active pharmaceutical ingredients (API).

Perrigo Specialty Pharmaceuticals 8 Campus DriveParsippany, NJ 07054www.perrigo.comBooth # 28

SLACK Incorporated is a leading publisher of Ophthalmology books and peer-reviewed journals. Covering the latest cutting-edge topics in multi-

ple specialty areas, including refractive and cataract surgery. Visit our booth today to see our newest releases as well as our top sellers.

SLACK Incorporated 6900 Grove RoadThorofare, NJ 08086www.Healio.comBooth # 24, 25

Sightpath Medical is the leading U.S. provider of on-demand equipment and

services for cataract and refractive surgery. Sightpath makes advanced ophthalmic sur-gical services an economic possibility wher-ever and whenever demand exists. Our mobile and fixed-location solutions enable ophthalmologists and health care facilities to provide better, more convenient care to their patients. Call 800-728-9615 to learn more about our refractive, cataract or laser-assisted cataract services, or visit our web-site www.sightpathmedical.com.

Sightpath Medical5775 W. Old Shakopee Road, Suite 90Bloomington, MN 55437www.sightpathmedical.comBooth # 27

30

S P E C I A L A D V E R T I S I N G S E C T I O N

Synergetics is proud to announce the launch of the new VersaVIT2.0 Vitrec-

tomy System, the market’s first and only simplified, small-form vitrectomy system providing retina surgeons and ASCs cre-ative solutions to yield operational effi-ciency and financial solvency — regardless of their current vitrectomy system.

Developed with surgeons’ input to meet the changing market dynamics, Versa-VIT2.0 was designed to be simple yet effec-tive, powerful but compact and most of all provide surgeons with meaningful features capable of potentially saving your facility money, including 6000 cuts/minute, duty cycle control and LED illumination. Let us show you how VersaVIT2.0 is changing the landscape of vitrectomy surgery.

Synergetics3845 Corporate Centre DriveO’Fallon, MO 63368www.synergeticsusa.comBooth # 20

The TearLab Osmolarity System is the first objective and quantitative test for diagnosing and managing dry eye disease. Fast and accurate

results are available in seconds using only 50 nanoliters (nL) of tear film. CMS Reimbursement $45.08 per patient (in the US only). CPT Code 83861QW. FDA 510(k) cleared. CLIA waived. CE Marked.

TearLab9980 Huennekens St., Suite 100San Diego, CA 92121www.tearlab.comBooth # 8

Product Showcase

Exhibit Hall ListingsAbbott Medical Optics ...................................7

Alcon ..................................................... 21, 22

Bausch + Lomb .........................................1, 2

Carl Zeiss Meditec ........................................15

Diopsys Inc. ................................................29

Doctors Allergy Formula ..............................32

Doctorsinternet.com ...................................31

Healio.com/Ocular Surgery NewS ........ 24, 25

Heidelberg Engineering ..............................26

i-Optics .......................................................30

Imprimis .....................................................10

Katena Products Inc. .....................................4

Ocular Therapeutix Inc. . ..............................18

Omeros Corporation ....................................14

Perrigo Specialty Pharmaceuticals ..............28

PRN Physician Recommended Nutriceuticals.......5

Sightpath Medical .......................................27

SLACK Incorporated ............................... 24, 25

Synergetics ..................................................20

TearLab Corp. ................................................8

E xhibitors at the Ocular Surgery NewS New York 2014 Symposium were invited to send a description of

products that will be displayed at this year’s meeting, to be held in New York City on November 14-16. All claims made in the descriptions are those of the manufacturer. Appearance of a product does not constitute an endorse-ment by Ocular Surgery NewS, the publisher or the Edi-torial Board.

OSN New York 2014 Product Showcase 31